t(2;11)(q33;q23) KMT2A/ABI2
2014-06-01 Eva A Coenen  , C Michel Zwaan  , Marry M van den Heuvel-Eibrink  , Claus Meyer  , Rolf Marschalek  , Ursula Creutzig  , Rob Pieters  , Jutta Bradtke   Affiliation1.Department of Pediatric Oncology and Hematology, Erasmus MC, Sophia Childrens Hospital, Rotterdam, The Netherlands; Institute of Pharmaceutical Biology, ZAFES, Diagnostic Center of Acute Leukemias (DCAL), Frankfurt, Germany; AML-BFM Study Group, Hannover, Germany; Department of Pediatric Hematology and Oncology, Justus-Liebig-University, Giessen, Germany; [email protected]
2.Department of Pediatric Oncology and Hematology, Erasmus MC, Sophia Children s Hospital, Rotterdam, The Netherlands; Institute of Pharmaceutical Biology, ZAFES, Diagnostic Center of Acute Leukemias (DCAL), Frankfurt, Germany; AML-BFM Study Group, Hannover, Germany; Department of Pediatric Hematology and Oncology, Justus-Liebig-University, Giessen, Germany; [email protected]
Clinics and Pathology
Disease
Clinics
Genes Involved and Proteins
Result of the Chromosomal Anomaly

Transcript
Detection protocole
Article Bibliography
| Pubmed ID | Last Year | Title | Authors |
|---|---|---|---|
| 22304832 | 2012 | Abl-interactor 2 (ABI2): a novel MLL translocation partner in acute myeloid leukemia. | Coenen EA et al |
Summary
Fusion gene
Citation
Eva A Coenen ; C Michel Zwaan ; Marry M van den Heuvel-Eibrink ; Claus Meyer ; Rolf Marschalek ; Ursula Creutzig ; Rob Pieters ; Jutta Bradtke
t(2;11)(q33;q23) KMT2A/ABI2
Atlas Genet Cytogenet Oncol Haematol. 2014-06-01
Online version: http://atlasgeneticsoncology.org/haematological/2159/t(2
